Skip to main content
Category

Uncategorized

faes-logo

Advanced Studies in Technology Transfer – Foundation for Advanced Education in the Sciences

By Uncategorized

faes-logo

On Tuesday, January 7th from 4-7 pm there will be an open house for the spring courses in the “Advanced Studies in Technology Transfer” certificate program at the FAES Graduate School at NIH in the new FAES Classroom & Bookstore complex in Building 10 / B1 level. For the semester beginning on January 27th there will be 10 courses available with enrollment open to the general community:

  • TECH 503 – Business Law Primer
  • TECH 506 – Research Commercialization Webinar Course: The Essentials
  • TECH 513 – Introduction to Technology Transfer
  • TECH 562 – How to Get a Job in Technology Transfer ***NEW***
  • TECH 566 – Biotechnology Business Leadership & Management Strategies
  • TECH 582 – Intellectual Property and Patent Prosecution for Scientists
  • TECH 584 – Translational Medical Product Development
  • TECH 586 – International Science, Technology and Innovation Policy
  • TECH 607 – Capstone Course in Technology Transfer
  • PHAR 500 – Principles of Clinical Pharmacology

More details can be found in the spring 2014 course catalog supplement (www.faes.org). Course credit is transferable as well into various MBA & MS degree programs at the University of Maryland University College (UMUC) Graduate School as well as the new Master of Biotechnology Enterprise and Entrepreneurship degree program at Johns Hopkins University.

Read More
wes-bush-northrop-grumman-image

Northrop Grumman, Hopkins partner on new healthcare start-up accelerator – The Washington Post

By Uncategorized

wes-bush-northrop-grumman-image

Defense and government contracting giant Northrop Grumman is making a bet on young start-ups by supporting a business accelerator for healthcare-related ventures.

The Falls Church-based company partnered with Johns Hopkins University, Rockville-based nonprofit BioHealth Innovation, which helps bioscience research projects in Maryland find funding, and Philadelphia venture capital firm DreamIt Ventures to start the new accelerator, to be based in Baltimore. DreamIt has operated similar programs for start-ups across other industries in several cities nationwide.

Read More

Identification of Gene Variants for Addiction Related Traits by Next-Gen Sequencing in Model Organisms Selectively Bred for Addiction Traits (UH2/UH3)

By Uncategorized

The goals of this initiative are to: 1) develop strategies and methodologies for the sequencing, mapping and genomic analyzing of established phenotypes of selectively bred animal models with addiction traits, and 2) identify, from new or existing selectively bred animal models, genetic variants with implications for addiction related traits.

Read More

Advances in Patient Safety through Simulation Research (R18)

By Uncategorized

The Agency for Healthcare Research and Quality (AHRQ) is interested in funding a diverse set of projects that develop, test and evaluate various simulation approaches for the purpose of improving the safe delivery of health care. Simulation in health care serves multiple purposes. As a training technique, it exposes individuals and teams to realistic clinical challenges through the use of mannequins, task trainers, virtual reality, standardized patients or other forms, and allows participants to experience in real-time the consequences of their decisions and actions. The principal advantage of simulation is that it provides a safe environment for health care practitioners to acquire valuable experience without putting patients at risk. Simulation also can be used as a test-bed to improve clinical processes and to identify failure modes or other areas of concern in new procedures and technologies that might otherwise be unanticipated and serve as threats to patient safety. Yet another application of simulation focuses on the establishment of valid and reliable measures of clinical performance competency and their potential use for credentialing and certification purposes. Applications that address a variety of simulation techniques, clinical settings, provider groups, priority populations, patient conditions, and threats to safety are welcomed.

Read More
leggett-china-asianfortune-image

Montgomery County Business Leaders and Government Officials Visit China to Strengthen Ties – Asian Fortune

By Uncategorized

leggett-china-asianfortune-image

From Sept. 15-25, Montgomery County executive Ike Leggett led a trip for four cities in China: Shanghai, Xi’an, Benxi, and the Gu’an County right outside of Beijing. The trip included over 80 business, education, and government leaders from Montgomery County and the DC metropolitan area including Montgomery County Public Schools (MCPS) superintendent Joshua Starr, county council member Hans Riemer, and Michael Goldman of the Washington Metro Area Transit Authority (WMATA).

This marked the first trade trip to china in five years by the county Executive’s office – the last one was in 2008.

The purpose of this mission was to encourage Chinese investors to consider Montgomery County as an attractive location for their investments, open doors for MoCo businesses there, as well as establish a “Sister City” relationship with the city of Xi’an, said a press release put out by the Montgomery County Office of Public Information.

Read More
dreamit-health-baltimore-logo

DreamIt Health Baltimore Kickoff – Save the Date: January 17th and 18th

By Uncategorized

dreamit-health-baltimore-logo

SAVE THE DATE: DreamIt Health Baltimore 2014
Kickoff Weekend: January 17th and 18th, 2014
Baltimore, MD

DreamIt Health Baltimore – powered by The Johns Hopkins University, BioHealth Innovation, and Northrop Grumman – is ramping up for the Winter 2014 accelerator class in Baltimore, MD and we want to make sure the kickoff events are on your calendar. More information below.

DreamIt Health Baltimore Kickoff Reception: January 17, 2013
On the evening of Friday, January 17th, 2014 DreamIt Ventures and our partners are hosting a kickoff party to meet the DreamIt Health Baltimore 2014 companies and other members of the Baltimore entrepreneurial community. Location is TBD and the event will begin around 5:30/6:00pm eastern time. We will be sending formal invitations to the event in the near future but wanted to get this on your calendar now. Please ink us in!

The kickoff reception will include light snacks and beverages, in addition to networking and your first opportunity to meet the DreamIt Health Baltimore 2014 companies.

Sponsored by:

NewImage

Kickoff Weekend Working Session: Saturday, January 18, 2014 – 9:00am – 5:00pm (INVITE ONLY)
We are in the process of identifying potential mentors for the companies as well as pairing them up with their law firm & accounting firm partners. Members of this community should please save the date for our working session that Saturday with the companies. We’ll send out a detailed RSVP for the event soon.

If you have any questions about either of these events or the DreamIt Health Baltimore program please contact Dana Rygwelski (dana@dreamitventures.com).

Read More
seeto-medimmune-bhi-board-image

BHI Elects MedImmune’s Reg Seeto, M.D. to Board of Directors

By Uncategorized

seeto-medimmune-bhi-board-image

BioHealth Innovation, Inc. (BHI), a regional private-public partnership focusing on commercializing market-relevant biohealth innovations and increasing access to early-stage funding in Central Maryland, announced today that Reg Seeto, M.D., has been appointed to the BHI Board of Directors. Dr. Seeto currently serves as Vice President, Head of Partnering & Strategy at MedImmune, the global biologics research and development arm of AstraZeneca.  

“It is a pleasure to welcome Reg to the BHI Board of Directors,” said Doug Liu, Chair, BHI Board of Directors, and Senior Vice President of Global Operations for Qiagen. “Reg’s background in business development and partnering strategy will be an important asset to our Board as we give counsel to BHI in its fostering of startups in Central Maryland. We look forward to his contributions to this Board, to the BHI organization, and to the biohealth startup community.”

Dr. Seeto rejoined the MedImmune Leadership Team in 2013 to lead the Partnering and Strategy Group after having spent a year as an executive abroad for AstraZeneca. He is responsible for MedImmune’s Business Development and Strategy teams, which deliver external partnership strategy for the organization. 

Read More

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.